These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25808533)

  • 1. Molecular action of metformin in hepatocytes: an updated insight.
    Sliwinska A; Drzewoski J
    Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism.
    Alshawi A; Agius L
    J Biol Chem; 2019 Feb; 294(8):2839-2853. PubMed ID: 30591586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
    Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
    Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The target of metformin in type 2 diabetes.
    Ferrannini E
    N Engl J Med; 2014 Oct; 371(16):1547-8. PubMed ID: 25317875
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation.
    Moonira T; Chachra SS; Ford BE; Marin S; Alshawi A; Adam-Primus NS; Arden C; Al-Oanzi ZH; Foretz M; Viollet B; Cascante M; Agius L
    J Biol Chem; 2020 Mar; 295(10):3330-3346. PubMed ID: 31974165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
    Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
    Wang Y; An H; Liu T; Qin C; Sesaki H; Guo S; Radovick S; Hussain M; Maheshwari A; Wondisford FE; O'Rourke B; He L
    Cell Rep; 2019 Nov; 29(6):1511-1523.e5. PubMed ID: 31693892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.
    Argaud D; Roth H; Wiernsperger N; Leverve XM
    Eur J Biochem; 1993 May; 213(3):1341-8. PubMed ID: 8504825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.
    Madiraju AK; Qiu Y; Perry RJ; Rahimi Y; Zhang XM; Zhang D; Camporez JG; Cline GW; Butrico GM; Kemp BE; Casals G; Steinberg GR; Vatner DF; Petersen KF; Shulman GI
    Nat Med; 2018 Sep; 24(9):1384-1394. PubMed ID: 30038219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.
    Stephenne X; Foretz M; Taleux N; van der Zon GC; Sokal E; Hue L; Viollet B; Guigas B
    Diabetologia; 2011 Dec; 54(12):3101-10. PubMed ID: 21947382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone and dehydroepiandrosterone permit gluconeogenic hormone responses in hepatocytes.
    Kneer N; Lardy H
    Arch Biochem Biophys; 2000 Mar; 375(1):145-53. PubMed ID: 10683260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
    Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
    Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.
    Fujita Y; Hosokawa M; Fujimoto S; Mukai E; Abudukadier A; Obara A; Ogura M; Nakamura Y; Toyoda K; Nagashima K; Seino Y; Inagaki N
    Diabetologia; 2010 Jul; 53(7):1472-81. PubMed ID: 20349346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).
    Cao J; Meng S; Chang E; Beckwith-Fickas K; Xiong L; Cole RN; Radovick S; Wondisford FE; He L
    J Biol Chem; 2014 Jul; 289(30):20435-46. PubMed ID: 24928508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin's Therapeutic Efficacy in the Treatment of Diabetes Does Not Involve Inhibition of Mitochondrial Glycerol Phosphate Dehydrogenase.
    MacDonald MJ; Ansari IH; Longacre MJ; Stoker SW
    Diabetes; 2021 Jul; 70(7):1575-1580. PubMed ID: 33849997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes.
    Otto M; Breinholt J; Westergaard N
    Diabetes Obes Metab; 2003 May; 5(3):189-94. PubMed ID: 12681026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes.
    Fulgencio JP; Kohl C; Girard J; Pégorier JP
    Biochem Pharmacol; 2001 Aug; 62(4):439-46. PubMed ID: 11448453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.
    Large V; Beylot M
    Diabetes; 1999 Jun; 48(6):1251-7. PubMed ID: 10342812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.